Search Back New search Go to resultsDiseaseMain groupHematologic NeoplasmsProtocol groupAcute LeukemiasAggressive LymphomasT-Cell and NK-Cell NeoplasmsDiseaseAcute Lymphoblastic LeukaemiaNHL, B-Cell Type, Anaplastic Large Cell Lymphoma, ALK-PositiveNHL, B-Cell Type, Burkitt's LymphomaNHL, B-Cell Type, Lymphoblastic LymphomaNHL, T-Cell Type, Lymphoblastic LymphomaSubgroupB-ALLICD10C83.5C83.7C84.6C91.0-MeSHPrecursor B-Cell Lymphoblastic Leukemia-LymphomaSequenceGMALL 08/2013-B-ALL/NHL 2002 Regimen, 18 - 55GMALL 08/2013-B-ALL/NHL 2002 regimen, older than 55, B-ALL onlyGMALL 08/2013-B-ALL/NHL 2002 regimen, older than 55, NHL onlyChemotherapyChemo-substanceCyclophosphamideCytarabineDexamethasoneDoxorubicinEtoposideIfosfamideMethotrexatePrednisoloneRituximabVincristineVindesineChemo-substanceCyclophosphamideCytarabineDexamethasoneDoxorubicinEtoposideIfosfamideMethotrexatePrednisoloneRituximabVincristineVindesineChemo-substanceCyclophosphamideCytarabineDexamethasoneDoxorubicinEtoposideIfosfamideMethotrexatePrednisoloneRituximabVincristineVindesineChemo-substanceCyclophosphamideCytarabineDexamethasoneDoxorubicinEtoposideIfosfamideMethotrexatePrednisoloneRituximabVincristineVindesineNo. Substances1367 RadiotherapySupportive therapySupportive substanceAmphotericin BBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneDextrose 5%DimetindenFolinic acidFosaprepitantFurosemideGranisetronMesnaNaCl 0.9%ParacetamolPegfilgrastimPotassium chloridePrednisoloneSodium BicarbonateSupportive substanceAmphotericin BBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneDextrose 5%DimetindenFolinic acidFosaprepitantFurosemideGranisetronMesnaNaCl 0.9%ParacetamolPegfilgrastimPotassium chloridePrednisoloneSodium BicarbonateSupportive substanceAmphotericin BBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneDextrose 5%DimetindenFolinic acidFosaprepitantFurosemideGranisetronMesnaNaCl 0.9%ParacetamolPegfilgrastimPotassium chloridePrednisoloneSodium BicarbonateSupportive substanceAmphotericin BBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneDextrose 5%DimetindenFolinic acidFosaprepitantFurosemideGranisetronMesnaNaCl 0.9%ParacetamolPegfilgrastimPotassium chloridePrednisoloneSodium BicarbonateNo. Substances41516Protocol classificationTherapy classificationcurrent standardIntensityhigh doseStandard doseTherapy indicationFirst lineTherapy phaseInductionPre-phaseTherapy intentioncurativeRisksAnemia Hb below 8g/dlEmetogenicity (MASCC/ESMO)FatigueFebrile NeutropeniaInfectionsNeutropeniaOral MucositisThrombocytopenia below 50 000/µl only studiesPublicationAuthorHoelzer DDiseaseHochmaligne B-ALL und B-NHL bei Erwachsenen, ErstlinieOriginGerman Multicenter Study Group for Adult Acute Lymphoblastic LeukemiaProtocols in Revision 5 protocols foundProtocols under revision.GMALL 08/2013 - B-ALL/NHL 2002 Regimen, 18 - 55, Part A (PID344 V1.2)GMALL 08/2013 - B-ALL/NHL 2002 Regimen, 18 - 55, Part B (PID346 V1.2)GMALL 08/2013 - B-ALL/NHL 2002 Regimen, 18 - 55, Part C (PID347 V1.1)GMALL 08/2013 - B-ALL/NHL 2002 regimen, all ages, Pre-phase (PID345 V1.0)GMALL 08/2013 - B-ALL/NHL 2002 regimen, Rituximab consolidation (PID784 V1.0)
